Vanguard Global Advisers
PFE icon

Vanguard Global Advisers’s Pfizer PFE Stock Holding History

Vanguard Global Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308M Sell
12,795,058
-110,838
-0.9% -$2.9M 0.14% 102
2026
Q1 		$362M Buy
+12,905,896
New +$344M 0.19% 81

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Global Advisers's PFE Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Pfizer (PFE) stake by 0.86% in Q2 2026, selling an estimated $2.9M and leaving 12,795,058 shares worth $308M. The position accounts for 0.14% of the portfolio, ranked #102.

Vanguard Global Advisers first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $362M in Q1 2026. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vanguard Global Advisers held 12,795,058 shares of Pfizer worth $308M as of Q2 2026.
  • Vanguard Global Advisers sold 110,838 Pfizer shares in Q2 2026, an estimated $2.9M.
  • Pfizer made up 0.14% of Vanguard Global Advisers's portfolio in Q2 2026, its #102 holding.
  • Vanguard Global Advisers first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Pfizer position peaked at $362M in Q1 2026.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.